Enter Search

Irritable Bowel Syndrome - Symptoms - Diets

Are Irritable Bowel Syndrome Candida Symptoms Linked?

There rationale for coming to this conclusion tends to be because they consider people most at risk of Candida overgrowth are those whose immune system has become repressed either through an illness, poor nutrition or through taking medication.

Yet, there are a considerable number of disc...


What You Need to Know About Irritable Bowel Syndrome

IBS, or Irritable Bowel Syndrome, affects an estimated 15-20% of the population today, which is more than depression, diabetes, and asthma combined. This troubling condition that is physical in nature rather than psychological is characterized by a series of symptoms generally occurring in the ...


Do You Suffer From Irritable Bowel Syndrome Migraine Pain?

There have been a number of studies carried out about the impact of IBS symptoms, including irritable bowel syndrome migraine problems. These studies have shown that people who suffer from Irritable Bowel Syndrome are at an increased risk for suffering from migraines, fibromyalgia and depressi...


Is Irritable Bowel Syndrome Worth Americas Research Dollars?

The recent past has leveled a heavy blow to hundreds of thousands of people who suffer from Irritable Bowel Syndrome. Novartis was asked to halt its sales of Zelnorm, at least in the United States. Used mostly by women for the treatment of IBS symptoms, the removal of Zelnorm leaves the pool of...


Latest irritable bowel syndrome Updates


Newsletter Sign up (ThirdAge)
Dear Dr. Susan- I have been diagnosed with irritable bowel syndrome but there was not much help from the Dr, who said I would have to try to figure it out and to live with it.

Soluble Fiber, Antispasmodics And Peppermint Oil Should Be Used To Treat Irritable Bowel Syndrome, Study Suggests (Science Daily)
Fiber, antispasmodics and peppermint oil are all effective therapies for irritable bowel syndrome and should become first-line treatments, according to a new study.

Sucampo Completes Enrollment in Phase 3 Pivotal Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (Business Wire via Yahoo! Finance)
BETHESDA, MD----Sucampo Pharmaceuticals, Inc. today announced that it has completed enrollment and initial dosing of patients in two pivotal phase 3 trials of lubiprostone for the treatment of Opioid-Induced Bowel Dysfunction .